IRulya Therapeutics QNCX
NASDAQ QNCX
$34.68 -5.59 (-13.88%)
At close: Oct 21, 2026 · 4:00 PM EDT

Quince Therapeutics, Inc. (QNCX) Consolidated Net Income (2018 - 2026)

Updated

IRulya Therapeutics (QNCX) posted Consolidated Net Income of -$75.51 million for Q2 2026, compared with -$16.05 million a year earlier.

Analysis

Quince Therapeutics, Inc. (QNCX) Consolidated Net Income (2018 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Consolidated Net Income at IRulya Therapeutics was -$92.5 million; for FY2025, it came in at -$83.98 million.

  • In prior years, IRulya Therapeutics' Consolidated Net Income was -$56.83 million in FY2024, -$31.39 million in FY2023 and -$51.66 million in FY2022.
  • The Q2 2026 figure stands as the lowest quarterly Consolidated Net Income in data going back to Q1 2018.
  • According to Business Quant data, Consolidated Net Income for the three prior quarters was $35.91 million (Q1 2026), -$39.46 million (Q4 2025) and -$13.44 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -75.51 Mn
Mar 31, 2026 35.91 Mn
Dec 31, 2025 -39.46 Mn
Sep 30, 2025 -13.44 Mn
Jun 30, 2025 -16.05 Mn
Mar 31, 2025 -15.03 Mn
Dec 31, 2024 -12.46 Mn
Sep 30, 2024 -5.49 Mn
Jun 30, 2024 -27.73 Mn
Mar 31, 2024 -11.15 Mn
Dec 31, 2023 -8.89 Mn
Sep 30, 2023 -5.35 Mn
Jun 30, 2023 -4.89 Mn
Mar 31, 2023 -12.25 Mn
Dec 31, 2022 -5.53 Mn
Sep 30, 2022 -7.92 Mn
Jun 30, 2022 -16.56 Mn
Mar 31, 2022 -21.64 Mn
Dec 31, 2021 66.55 Mn
Sep 30, 2021 -21.71 Mn
API Access

Quince Therapeutics, Inc. Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=QNCX&period=max&api_key=YOUR_API_KEY